WHAT THIS PROGRAM SUPPORTS

Provider-guided weight management support built around long-term results.

Structured cash-pay programs that may include GLP-1-based treatment support, provider oversight, lab review, and ongoing monitoring when clinically appropriate.

Treatment is not guaranteed. Prescriptions are issued only when clinically appropriate.

Weight Management Support

Weight Management

Appetite Regulation

Intake

HOW IT WORKS

Provider Review

Complete a detailed intake about your health, symptoms, and goals.

Metabolic Health

Active Lifestyle Goals

Long-Term Accountability

SEMAGLUTIDE

Price includes all doses, supplies and cold shipping.

A licensed provider reviews your information and determines next steps.

Pharmacy Coordination

If appropriate, your treatment is coordinated through a licensed compounding pharmacy.

MONTHLY

$349

Best for patients who want to try it before they commit

3-MONTH PROGRAM

6-MONTH PROGRAM

$972

Save $75 compared to monthly billing

Effective monthly price: $324/month

$1,794

Save $300 compared to monthly billing

Effective monthly price: $299/month

TIRZEPATIDE

Ongoing Support

We monitor progress and make adjustments to help you reach your goals.

MONTHLY

$499

Best for patients who want to try it before they commit

3-MONTH PROGRAM

6-MONTH PROGRAM

$1,422

Save $75 compared to monthly billing

Effective monthly price: $474/month

$2,694

Save $300 compared to monthly billing

Effective monthly price: $449/month

Price includes all doses, supplies and cold shipping.

Provider evaluation

Adults with weight loss goals

Individuals seeking appetite and portion control support

GLP-1 receptor agonist support that may help with appetite regulation, weight management, and metabolic health when clinically appropriate.

Patients looking for long-term lifestyle and health improvements

Intake and eligibility review

Lab review when appropriate

Provider-guided planning

Pharmacy coordination

  • Semaglutide and tirzepatide are both once weekly injectable medications commonly considered in provider-guided weight management programs, but they work slightly differently in the body. Semaglutide primarily targets the GLP-1 pathway involved in appetite regulation and metabolic support, while tirzepatide targets both GLP-1 and GIP pathways. Providers determine the most appropriate option based on individual goals, medical history, and treatment response.

  • Focusing on appetite regulation, portion control, metabolic health, and long-term wellness goals we work together to determine the appropriate amount of calories, protein, water physical activity and medication dosage (if applicable) with the intention of lifestyle modification and getting of any medication as quickly as possible.

    This once weekly injection is to be used as a tool to reach your goals as opposed to something to rely on long-term.

  • In some cases, providers may require baseline or follow-up lab work depending on medical history, treatment goals, current medications, and ongoing monitoring needs.

  • Some compound formulations may include pyridoxine, methylcobalamin, glycine, carnitine or other vitamins as part of a broader wellness-focused treatment approach. Providers will consider these formulations based on patient-specific goals, treatment tolerability considerations and pharmacy availability.

  • Results vary from patient to patient. Some individuals may begin noticing appetite-related changes or weight management support within the first several weeks, while longer-term wellness and body composition goals typically develop gradually over time alongside lifestyle consistency and provider-guided monitoring.

  • Some patients may experience gastrointestinal-related side effects such as nausea, fullness, bloating, constipation, or appetite changes. Providers review medical history, treatment tolerance, and ongoing response throughout care to help support safe and appropriate treatment planning.

  • Yes. Long-term wellness and weight management outcomes are typically best supported through a combination of provider-guided treatment, nutrition, movement, recovery, and sustainable lifestyle habits. This is the key to true long-lasting change.

Providers evaluate medical history, contraindications, medication interactions, and patient-specific goals before determining whether treatment is appropriate.

Continued adjusting and optimizing

SAFETY & MONITORING

Built around safety and oversight.

WHO THIS IS FOR

SEMAGLUTIDE

Those seeking provider-guided, medically supervised support

AVAILABLE SUPPORT OPTIONS

VS

PROGRAM FEATURES

Targets GLP-1 pathway

Supports appetite regulation and hunger control

May support gradual, steady weight management

Dual GIP + GLP-1 receptor agonist support that may help with appetite regulation, metabolic function, and weight management when clinically appropriate.

TIRZEPATIDE

Supports appetite regulation and satiety

Supports greater weight loss potential for some patients

Targets GIP and GLP-1 pathway

Start your weight management journey with confidence.

Personalized support. Provider oversight. Real results.